{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:48:35Z","timestamp":1792212515322,"version":"4.4.0"},"reference-count":160,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004505","name":"Universit\u00e0 di Catania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.pharmthera.2019.07.003","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T11:13:03Z","timestamp":1562670783000},"page":"107392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":153,"special_numbering":"C","title":["Dopamine outside the brain: The eye, cardiovascular system and endocrine pancreas"],"prefix":"10.1016","volume":"203","author":[{"given":"Claudio","family":"Bucolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Marco","family":"Leggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Drago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Salomone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2019.07.003_bb0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1081\/CEH-100100077","article-title":"Localization of dopamine receptor subtypes in systemic arteries","volume":"22","author":"Amenta","year":"2000","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0010","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1093\/ajh\/3.6.34S","article-title":"Autoradiographic localization of vascular dopamine receptors","volume":"3","author":"Amenta","year":"1990","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0015","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/002215540305100806","article-title":"Expression of the two isoforms of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumors","volume":"51","author":"Anlauf","year":"2003","journal-title":"Journal of Histochemistry and Cytochemistry"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0020","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.trsl.2014.07.006","article-title":"The renal dopaminergic system: Novel diagnostic and therapeutic approaches in hypertension and kidney disease","volume":"165","author":"Armando","year":"2015","journal-title":"Translational Research"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0025","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.cellsig.2011.02.008","article-title":"Role of G(i\/o)-Src kinase-PI3K\/Akt pathway and caveolin-1 in beta(2)-adrenoceptor coupling to endothelial NO synthase in mouse pulmonary artery","volume":"23","author":"Banquet","year":"2011","journal-title":"Cellular Signalling"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11920-015-0637-2","article-title":"Circadian clocks as modulators of metabolic comorbidity in psychiatric disorders","volume":"17","author":"Barandas","year":"2015","journal-title":"Current Psychiatry Reports"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-5728(95)00044-3","article-title":"Enhanced tumor growth in brain dopamine-depleted mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment","volume":"60","author":"Basu","year":"1995","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0040","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/307371a0","article-title":"Beta-adrenergic modulation of calcium channels in frog ventricular heart cells","volume":"307","author":"Bean","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0045","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0050","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2005.05.012","article-title":"An Akt\/beta-arrestin 2\/PP2A signaling complex mediates dopaminergic neurotransmission and behavior","volume":"122","author":"Beaulieu","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0055","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1523\/JNEUROSCI.5074-06.2007","article-title":"Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo","volume":"27","author":"Beaulieu","year":"2007","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0060","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/(SICI)1097-0231(19980615)12:11<683::AID-RCM218>3.0.CO;2-N","article-title":"Identification of catecholamines in the immune system by electrospray ionization mass spectrometry","volume":"12","author":"Bergquist","year":"1998","journal-title":"Rapid Communications in Mass Spectrometry"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0065","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1007\/BF00171012","article-title":"Localization of IBF as a D-2 dopamine receptor imaging agent in nonhuman primates","volume":"20","author":"Billings","year":"1993","journal-title":"European Journal of Nuclear Medicine"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025537","article-title":"Dopamine receptors in human adipocytes: Expression and functions","volume":"6","author":"Borcherding","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0075","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.bcp.2011.11.031","article-title":"Dopamine-(3) receptor modulates intraocular pressure: Implications for glaucoma","volume":"83","author":"Bucolo","year":"2012","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0080","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.exer.2018.06.006","article-title":"Expression of dopamine D2 and D3 receptors in the human retina revealed by positron emission tomography and targeted mass spectrometry","volume":"175","author":"Caravaggio","year":"2018","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0085","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/hy0901.096422","article-title":"Theodore Cooper lecture: Renal dopamine system: Paracrine regulator of sodium homeostasis and blood pressure","volume":"38","author":"Carey","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0090","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/00003226-199911000-00016","article-title":"Localization of dopamine receptors in the rabbit cornea","volume":"18","author":"Cavallotti","year":"1999","journal-title":"Cornea"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0095","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1010611419602","article-title":"Determination of dopamine D1 receptors in the human uveo scleral tissue by light microscope autoradiography","volume":"23","author":"Cavallotti","year":"1999","journal-title":"International Ophthalmology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0100","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1212\/WNL.0b013e3182553cc9","article-title":"Clinical features of Parkinson disease when onset of diabetes came first: A case-control study","volume":"78","author":"Cereda","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0105","doi-asserted-by":"crossref","first-page":"157698","DOI":"10.1155\/2015\/157698","article-title":"Timed Bromocriptine-QR therapy reduces progression of cardiovascular disease and dysglycemia in subjects with well-controlled type 2 diabetes mellitus","volume":"2015","author":"Chamarthi","year":"2015","journal-title":"Journal Diabetes Research"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0110","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00441-014-1894-9","article-title":"Distinctive expression and cellular distribution of dopamine receptors in the pancreatic islets of rats","volume":"357","author":"Chen","year":"2014","journal-title":"Cell and Tissue Research"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000265247","article-title":"Dopaminergic involvement in intraocular pressure in the rabbit eye","volume":"15","author":"Chiou","year":"1983","journal-title":"Ophthalmic Research"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0120","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1006\/exer.1999.0734","article-title":"Potential sites of action of TNPA: A dopamine-2 receptor agonist","volume":"69","author":"Chu","year":"1999","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0125","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0022-3565(24)39290-0","article-title":"Mechanisms and sites of ocular action of 7-hydroxy-2-dipropylaminotetralin: A dopamine(3) receptor agonist","volume":"293","author":"Chu","year":"2000","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0130","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/1098-2396(200008)37:2<125::AID-SYN7>3.0.CO;2-7","article-title":"Dopamine D(5) receptor immunolocalization in rat and monkey brain","volume":"37","author":"Ciliax","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0135","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/MJT.0b013e318160c353","article-title":"Effect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects","volume":"15","author":"Contreras","year":"2008","journal-title":"American Journal of Therapeutics"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0140","first-page":"1240","article-title":"Dopamine modulation of active ion transport in rabbit corneal epithelium","volume":"25","author":"Crosson","year":"1984","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0145","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.coph.2008.12.002","article-title":"Getting specialized: Presynaptic and postsynaptic dopamine D2 receptors","volume":"9","author":"De Mei","year":"2009","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0150","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/347072a0","article-title":"Molecular cloning and expression of the gene for a human D1 dopamine receptor","volume":"347","author":"Dearry","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0155","doi-asserted-by":"crossref","first-page":"H2327","DOI":"10.1152\/ajpheart.00993.2007","article-title":"Dopamine increases L-type calcium current more in newborn than adult rabbit cardiomyocytes via D1 and beta2 receptors","volume":"294","author":"Ding","year":"2008","journal-title":"American Journal of Physiology Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0160","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1097\/IJG.0000000000000343","article-title":"Early glaucoma screening using the ibopamine provocative test","volume":"25","author":"Dominguez-Duenas","year":"2016","journal-title":"Journal of Glaucoma"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0165","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/clpt.1991.30","article-title":"Intraocular pressure increases with fenoldopam, but not nitroprusside, in hypertensive humans","volume":"49","author":"Elliott","year":"1991","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0170","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1210\/en.2017-00639","article-title":"Regulation of endogenous (male) rodent GLP-1 secretion and human islet insulin secretion by antagonism of somatostatin receptor 5","volume":"158","author":"Farb","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0175","article-title":"New roles for dopamine D2 and D3 receptors in pancreatic beta cell insulin secretion","author":"Farino","year":"2019","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0180","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.exer.2018.01.008","article-title":"Concentration gradient of noradrenaline from the periphery to the Centre of the cornea - a clue to its origin","volume":"168","author":"Figueira","year":"2018","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0185","doi-asserted-by":"crossref","first-page":"H134","DOI":"10.1152\/ajpheart.00023.2009","article-title":"NO production and eNOS phosphorylation induced by epinephrine through the activation of beta-adrenoceptors","volume":"297","author":"Figueroa","year":"2009","journal-title":"American Journal of Physiology Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0190","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1124\/mol.107.043885","article-title":"Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization","volume":"74","author":"Fiorentini","year":"2008","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0195","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1073\/pnas.88.9.3772","article-title":"Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission","volume":"88","author":"Fremeau","year":"1991","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0200","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3389\/fnins.2017.00432","article-title":"Intrinsic and antipsychotic drug-induced metabolic dysfunction in schizophrenia","volume":"11","author":"Freyberg","year":"2017","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0205","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1475-2840-13-50","article-title":"Impaired dopamine D1 receptor-mediated vasorelaxation of mesenteric arteries in obese Zucker rats","volume":"13","author":"Fu","year":"2014","journal-title":"Cardiovascular Diabetology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0210","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/en.2009-0996","article-title":"Disruption of the dopamine d2 receptor impairs insulin secretion and causes glucose intolerance","volume":"151","author":"Garcia-Tornadu","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0215","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2337\/dc09-2009","article-title":"Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes","volume":"33","author":"Gaziano","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0220","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/eurheartj\/ehp598","article-title":"Amphetamines induce tissue factor and impair tissue factor pathway inhibitor: Role of dopamine receptor type 4","volume":"31","author":"Gebhard","year":"2010","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0225","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/jop.1987.3.291","article-title":"Hypotensive effect of bromocriptine in glaucomatous eyes","volume":"3","author":"Geyer","year":"1987","journal-title":"Journal of Ocular Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0230","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/HYPERTENSIONAHA.110.152256","article-title":"HK-2 human renal proximal tubule cells as a model for G protein-coupled receptor kinase type 4-mediated dopamine 1 receptor uncoupling","volume":"56","author":"Gildea","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0235","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.1073\/pnas.150241097","article-title":"Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes","volume":"97","author":"Gines","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0240","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/01.CIR.72.2.245","article-title":"Dopamine receptors: Applications in clinical cardiology","volume":"72","author":"Goldberg","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0245","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1124\/jpet.103.049270","article-title":"Sources and significance of plasma levels of catechols and their metabolites in humans","volume":"305","author":"Goldstein","year":"2003","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0250","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1373\/clinchem.2008.107193","article-title":"Neuronal source of plasma dopamine","volume":"54","author":"Goldstein","year":"2008","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0255","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1210\/jcem.84.7.5864","article-title":"Sources and physiological significance of plasma dopamine sulfate","volume":"84","author":"Goldstein","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0260","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1139\/y02-081","article-title":"Functional and autoradiographic characterization of dopamine D2-like receptors in the Guinea pig heart","volume":"80","author":"Gomez Mde","year":"2002","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0265","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0014-4835(81)80047-4","article-title":"Drug effects on aqueous humor formation and pseudofacility in normal rabbit eyes","volume":"33","author":"Green","year":"1981","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0270","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0014-4835(79)90059-9","article-title":"Dopamine stimulation of passive permeability and secretion in the isolated rabbit ciliary epithelium","volume":"29","author":"Green","year":"1979","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0275","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fphar.2019.00125","article-title":"GPCR signaling regulation: The role of GRKs and Arrestins","volume":"10","author":"Gurevich","year":"2019","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0280","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0022-3565(25)33333-1","article-title":"Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist","volume":"223","author":"Hahn","year":"1982","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0285","first-page":"H511","article-title":"Role of cAMP-dependent protein kinase in cAMP-mediated vasodilation","volume":"262","author":"Haynes","year":"1992","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0290","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/aas.13294","article-title":"Dopamine in critically ill patients with cardiac dysfunction: A systematic review with meta-analysis and trial sequential analysis","volume":"63","author":"Hiemstra","year":"2019","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0295","doi-asserted-by":"crossref","first-page":"18091","DOI":"10.1074\/jbc.M107731200","article-title":"Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors","volume":"277","author":"Hillion","year":"2002","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0300","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0404.1996.tb00187.x","article-title":"Sympathetic skin response in Parkinson's disease","volume":"93","author":"Hirashima","year":"1996","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0305","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrendo.2014.203","article-title":"Diabetes mellitus and severe mental illness: Mechanisms and clinical implications","volume":"11","author":"Holt","year":"2015","journal-title":"Nature Reviews. Endocrinology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0310","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ajh.2011.41","article-title":"Inhibitory effect of the D(3) dopamine receptor on insulin receptor expression and function in vascular smooth muscle cells","volume":"24","author":"Huang","year":"2011","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0315","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1053\/meta.2002.30525","article-title":"Phosphatidylinositol 3-kinase may mediate isoproterenol-induced vascular relaxation in part through nitric oxide production","volume":"51","author":"Isenovic","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0320","first-page":"56","article-title":"Dopaminergic suppression of pancreatic somatostatin secretion","volume":"101","author":"Itoh","year":"1982","journal-title":"Acta Endocrinologica"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0325","first-page":"657","article-title":"Localization of dopamine1A receptor mRNA in different vascular beds in rat: A nonradioactive in situ hybridization study","volume":"19","author":"Jin","year":"1997","journal-title":"Methods and Findings in Experimental and Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074116","article-title":"The dopamine D3 receptor knockout mouse mimics aging-related changes in autonomic function and cardiac fibrosis","volume":"8","author":"Johnson","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0335","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2007.06.059","article-title":"A proteomic approach to receptor signaling: Molecular mechanisms and therapeutic implications derived from discovery of the dopamine D2 receptor signalplex","volume":"572","author":"Kabbani","year":"2007","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0340","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00582573","article-title":"On the mechanism of beta-adrenergic regulation of the Ca channel in the Guinea-pig heart","volume":"405","author":"Kameyama","year":"1985","journal-title":"Pfl\u00fcgers Archiv \/ European Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0345","first-page":"1090","article-title":"Effects of dopamine receptor activation on the level of cyclic AMP in the trabecular meshwork","volume":"30","author":"Karnezis","year":"1989","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0350","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1097\/00006676-200408000-00019","article-title":"Relationships between the autonomic nervous system and the pancreas including regulation of regeneration and apoptosis: Recent developments","volume":"29","author":"Kiba","year":"2004","journal-title":"Pancreas"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0355","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1016-8478(23)13562-X","article-title":"Localization of dopamine D1 and D2 receptor mRNAs in the rat systemic and pulmonary vasculatures","volume":"9","author":"Kim","year":"1999","journal-title":"Molecules and Cells"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0360","doi-asserted-by":"crossref","first-page":"E1038","DOI":"10.1152\/ajpendo.00567.2005","article-title":"Activation of dopamine D2 receptors simultaneously ameliorates various metabolic features of obese women","volume":"291","author":"Kok","year":"2006","journal-title":"American Journal of Physiology Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0365","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/bcpt.12307","article-title":"Different effects of cabergoline and bromocriptine on metabolic and cardiovascular risk factors in patients with elevated prolactin levels","volume":"116","author":"Krysiak","year":"2015","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0370","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.neuropharm.2016.03.047","article-title":"The mood stabilizer valproic acid opposes the effects of dopamine on circadian rhythms","volume":"107","author":"Landgraf","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0375","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/0706743716644765","article-title":"Dopamine 2 receptor genes are associated with raised blood glucose in schizophrenia","volume":"61","author":"Lawford","year":"2016","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0380","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1101\/gr.212720.116","article-title":"Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes","volume":"27","author":"Lawlor","year":"2017","journal-title":"Genome Research"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0385","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1113\/jphysiol.1996.sp021621","article-title":"Dopamine (D2) receptor regulation of intracellular calcium and membrane capacitance changes in rat melanotrophs","volume":"495","author":"Lee","year":"1996","journal-title":"Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0390","doi-asserted-by":"crossref","first-page":"35671","DOI":"10.1074\/jbc.M401923200","article-title":"Dopamine D1 and D2 receptor co-activation generates a novel phospholipase C-mediated calcium signal","volume":"279","author":"Lee","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0395","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.bcp.2010.01.029","article-title":"The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cells","volume":"79","author":"de Leeuw van Weenen","year":"2010","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0400","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.pharmthera.2016.06.007","article-title":"Current drug treatments targeting dopamine D3 receptor","volume":"165","author":"Leggio","year":"2016","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0405","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1742-7843.2007.00177.x","article-title":"Effect of dopamine receptor 1 on apoptosis of cultured neonatal rat cardiomyocytes in simulated ischaemia\/reperfusion","volume":"102","author":"Li","year":"2008","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0410","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s12035-014-8762-1","article-title":"Activation of dopamine D1 receptors regulates dendritic morphogenesis through Rac1 and RhoA in prefrontal cortex neurons","volume":"51","author":"Li","year":"2015","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0415","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/01.CIR.44.2.163","article-title":"Acute hemodynamic effects of dopamine in patients with shock","volume":"44","author":"Loeb","year":"1971","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0420","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0014-4835(90)90079-A","article-title":"Biochemical and functional evidence for the presence of dopamine D1 receptors in the bovine ciliary body","volume":"51","author":"Lograno","year":"1990","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0425","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2015.12.029","article-title":"Dopaminergic drugs in type 2 diabetes and glucose homeostasis","volume":"109","author":"Lopez Vicchi","year":"2016","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0430","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1471-4159.2003.02038.x","article-title":"Potent activation of dopamine D3\/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole","volume":"87","author":"Maggio","year":"2003","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0435","doi-asserted-by":"crossref","first-page":"26016","DOI":"10.1074\/jbc.M710349200","article-title":"Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum","volume":"283","author":"Marcellino","year":"2008","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0440","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/syn.21501","article-title":"Increased affinity of dopamine for D(2) -like versus D(1) -like receptors relevance for volume transmission in interpreting PET findings","volume":"66","author":"Marcellino","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0445","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.parkreldis.2018.05.026","article-title":"Glucose dysregulation in Parkinson's disease: Too much glucose or not enough insulin?","volume":"55","author":"Marques","year":"2018","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0450","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1476-5381.1995.tb15884.x","article-title":"Renal vasodilatation by dopexamine and fenoldopam due to alpha 1-adrenoceptor blockade","volume":"115","author":"Martin","year":"1995","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0455","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0895-7061(99)00270-8","article-title":"Type 1A dopamine receptor expression in the heart is not altered in spontaneously hypertensive rats","volume":"13","author":"Matsumoto","year":"2000","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0460","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1172\/JCI104996","article-title":"Effect of dopamine in man: Augmentation of sodium excretion, glomerular filtration rate, and renal plasma flow","volume":"43","author":"McDonald","year":"1964","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0465","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/jnc.13732","article-title":"Dopamine D3 autoreceptor inhibition enhances cocaine potency at the dopamine transporter","volume":"138","author":"McGinnis","year":"2016","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0470","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(83)92699-5","article-title":"Bromocriptine lowers intraocular pressure without affecting blood pressure","volume":"1","author":"Mekki","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0475","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: From structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0480","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/schbul\/sbs082","article-title":"Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0485","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/schbul\/sbr148","article-title":"Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0490","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.1074\/jbc.RA117.001102","article-title":"Islet proteomics reveals genetic variation in dopamine production resulting in altered insulin secretion","volume":"293","author":"Mitok","year":"2018","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0495","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF00313602","article-title":"Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease","volume":"87","author":"Moroo","year":"1994","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0500","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijcard.2015.12.023","article-title":"Takotsubo cardiomyopathy induced by dopamine infusion after carotid artery stenting","volume":"205","author":"Nakagawa","year":"2016","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0505","doi-asserted-by":"crossref","first-page":"116S","DOI":"10.1093\/ajh\/3.6.116S","article-title":"The pharmacology of fenoldopam","volume":"3","author":"Nichols","year":"1990","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0510","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/j.1471-4159.2007.04660.x","article-title":"Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: Potential role of heterodimer formation","volume":"102","author":"Novi","year":"2007","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0515","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/01.HYP.27.3.693","article-title":"Expression of the subtype 1A dopamine receptor in the rat heart","volume":"27","author":"Ozono","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0520","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1161\/01.HYP.30.3.725","article-title":"Localization of the dopamine D1 receptor protein in the human heart and kidney","volume":"30","author":"Ozono","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0525","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.tins.2007.06.004","article-title":"Is dopamine a physiologically relevant mediator of feeding behavior?","volume":"30","author":"Palmiter","year":"2007","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0530","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.116.027121","article-title":"Pathophysiology of Takotsubo syndrome","volume":"135","author":"Pelliccia","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0535","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1113\/jphysiol.2013.262626","article-title":"Intrinsic vascular dopamine - a key modulator of hypoxia-induced vasodilatation in splanchnic vessels","volume":"592","author":"Pfeil","year":"2014","journal-title":"Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0540","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jamapsychiatry.2016.3803","article-title":"Impaired glucose homeostasis in first-episode schizophrenia: A systematic review and meta-analysis","volume":"74","author":"Pillinger","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0545","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/jop.1998.14.203","article-title":"Fenoldopam, a selective dopamine-1 receptor agonist, raises intraocular pressure in males with normal intraocular pressure","volume":"14","author":"Piltz","year":"1998","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0550","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.bcp.2013.08.010","article-title":"Regulation of intraocular pressure in mice: Structural analysis of dopaminergic and serotonergic systems in response to cabergoline","volume":"86","author":"Platania","year":"2013","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044316","article-title":"Homology modeling of dopamine D2 and D3 receptors: Molecular dynamics refinement and docking evaluation","volume":"7","author":"Platania","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0560","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/02713688209000771","article-title":"Effects of ergoline derivatives on intraocular pressure and iris function in rabbits and monkeys","volume":"2","author":"Potter","year":"1982","journal-title":"Current Eye Research"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0565","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1089\/jop.1987.3.309","article-title":"Cianergoline lowers intraocular pressure in rabbits and monkeys and inhibits contraction of the cat nictitans by suppressing sympathetic neuronal function","volume":"3","author":"Potter","year":"1987","journal-title":"Journal of Ocular Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0570","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1073\/pnas.1717194115","article-title":"Differential regulation of striatal motor behavior and related cellular responses by dopamine D2L and D2S isoforms","volume":"115","author":"Radl","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0575","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1677\/JOE-07-0632","article-title":"Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine","volume":"198","author":"Raffo","year":"2008","journal-title":"Journal of Endocrinology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0580","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1176\/appi.ajp.2016.16040442","article-title":"Endogenous and antipsychotic-related risks for diabetes mellitus in young people with schizophrenia: A Danish population-based cohort study","volume":"174","author":"Rajkumar","year":"2017","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0585","first-page":"2697","article-title":"Effects of dopamine on ciliary blood flow, aqueous production, and intraocular pressure in rabbits","volume":"43","author":"Reitsamer","year":"2002","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0590","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0047-6374(01)00361-X","article-title":"Age-related changes of dopamine receptor protein immunoreactivity in the rat mesenteric vascular tree","volume":"123","author":"Ricci","year":"2002","journal-title":"Mechanisms of Ageing and Development"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0595","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1474-8673.2006.00376.x","article-title":"Dopamine receptor subtypes in the human pulmonary arterial tree","volume":"26","author":"Ricci","year":"2006","journal-title":"Autonomic & Autacoid Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0600","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1126\/science.288.5463.154","article-title":"Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity","volume":"288","author":"Rocheville","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0605","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000114744","article-title":"Effects of long-term L-dopa therapy on carbohydrate metabolism in patients with Parkinson's disease","volume":"14","author":"Rosati","year":"1976","journal-title":"European Neurology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0610","doi-asserted-by":"crossref","first-page":"36824","DOI":"10.1074\/jbc.M505560200","article-title":"Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion","volume":"280","author":"Rubi","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0615","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF00501436","article-title":"Interactions of three inotropic agents, ASL-7022, dobutamine and dopamine, with alpha- and beta-adrenoceptors in vitro","volume":"326","author":"Ruffolo","year":"1984","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0620","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1097\/00003246-199108000-00010","article-title":"Thermogenic and metabolic effects of dopamine in healthy men","volume":"19","author":"Ruttimann","year":"1991","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0625","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10735-008-9195-9","article-title":"Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreas","volume":"39","author":"Saisho","year":"2008","journal-title":"Journal of Molecular Histology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0630","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fphar.2011.00009","article-title":"Selectivity and specificity of sphingosine-1-phosphate receptor ligands: Caveats and critical thinking in characterizing receptor-mediated effects","volume":"2","author":"Salomone","year":"2011","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0635","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1161\/CIRCRESAHA.108.178897","article-title":"Regulation of endothelial nitric oxide synthase and postnatal angiogenesis by Rac1","volume":"103","author":"Sawada","year":"2008","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0640","doi-asserted-by":"crossref","first-page":"30308","DOI":"10.1074\/jbc.M102297200","article-title":"D2\/D3 dopamine receptor heterodimers exhibit unique functional properties","volume":"276","author":"Scarselli","year":"2001","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0645","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40263-013-0054-1","article-title":"Antipsychotic-induced metabolic and cardiovascular side effects in schizophrenia: A novel mechanistic hypothesis","volume":"27","author":"Scigliano","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0650","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.ijo.0800893","article-title":"Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in Ob\/Ob mice treated with dopaminergic agonists","volume":"23","author":"Scislowski","year":"1999","journal-title":"International Journal of Obesity and Related Metabolic Disorders"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0655","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbr.2018.05.025","article-title":"High fat diet feeding induced insulin resistance exacerbates 6-OHDA mediated neurotoxicity and behavioral abnormalities in rats","volume":"351","author":"Sharma","year":"2018","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0660","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1210\/me.2012-1101","article-title":"Dopamine-mediated autocrine inhibitory circuit regulating human insulin secretion in vitro","volume":"26","author":"Simpson","year":"2012","journal-title":"Molecular Endocrinology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0665","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134157","article-title":"Expression profiles of neuropeptides, neurotransmitters, and their receptors in human keratocytes in vitro and in situ","volume":"10","author":"Sloniecka","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0670","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/HYPERTENSIONAHA.111.189605","article-title":"Endothelial cells are able to synthesize and release catecholamines both in vitro and in vivo","volume":"60","author":"Sorriento","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0675","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1464-5491.2007.02092.x","article-title":"Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia","volume":"24","author":"Spelman","year":"2007","journal-title":"Diabetic Medicine"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0680","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1210\/en.2003-0561","article-title":"Norepinephrine and epinephrine-deficient mice are hyperinsulinemic and have lower blood glucose","volume":"144","author":"Ste Marie","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0685","first-page":"1","article-title":"In-utero cold stress causes elevation of blood pressure via impaired vascular dopamine D1 receptor in offspring","author":"Sun","year":"2019","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0690","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2337\/dc11-2384","article-title":"Circulating dopamine and C-peptide levels in fasting nondiabetic hypertensive patients: The Graz endocrine causes of hypertension study","volume":"35","author":"Tomaschitz","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0695","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1124\/mol.104.003376","article-title":"Adenosine A2A receptor and dopamine D3 receptor interactions: Evidence of functional A2A\/D3 heteromeric complexes","volume":"67","author":"Torvinen","year":"2005","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2019.03.966","article-title":"Dopamine D1 and D2 receptors differentially regulate Rac1 and Cdc42 Signaling in the nucleus Accumbens to modulate Behavioral and structural plasticity after repeated methamphetamine treatment","author":"Tu","year":"2019","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0705","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000116308","article-title":"Correlation of autonomic dysfunction to CSF concentrations of noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's disease","volume":"26","author":"Turkka","year":"1987","journal-title":"European Neurology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0710","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4103\/ijccm.IJCCM_175_17","article-title":"The impact of dopamine on insulin secretion in healthy controls","volume":"22","author":"Underland","year":"2018","journal-title":"Indian Journal of Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0715","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1210\/me.2012-1226","article-title":"Dopamine synthesis and D3 receptor activation in pancreatic beta-cells regulates insulin secretion and intracellular [Ca(2+)] oscillations","volume":"26","author":"Ustione","year":"2012","journal-title":"Molecular Endocrinology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0720","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000126970","article-title":"Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat","volume":"63","author":"Uvnas-Moberg","year":"1996","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0725","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0197-4580(94)90053-1","article-title":"Dopamine D2, D3, and D4 receptor mRNA levels in rat brain and pituitary during aging","volume":"15","author":"Valerio","year":"1994","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0730","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/IJG.0b013e3182311db4","article-title":"Ibopamine: D1-dopaminergic agonist in the diagnosis of glaucoma","volume":"22","author":"Virno","year":"2013","journal-title":"Journal of Glaucoma"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0735","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.eurpsy.2009.11.011","article-title":"Analysis of HapMap tag-SNPs in dysbindin (DTNBP1) reveals evidence of consistent association with schizophrenia","volume":"25","author":"Voisey","year":"2010","journal-title":"European Psychiatry"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0740","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1085\/jgp.200409082","article-title":"Protein kinase activation increases insulin secretion by sensitizing the secretory machinery to Ca2+","volume":"124","author":"Wan","year":"2004","journal-title":"The Journal of General Physiology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0745","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0140-6736(00)03643-6","article-title":"Brain dopamine and obesity","volume":"357","author":"Wang","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0750","first-page":"691","article-title":"Comparison of the effects of dopamine1- and dopamine2-receptor agonists on the cAMP generating system in canine coronary and renal arteries","volume":"16","author":"Wang","year":"1994","journal-title":"Methods and Findings in Experimental and Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0755","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1475-2840-13-97","article-title":"Dopamine D(4) receptors inhibit proliferation and migration of vascular smooth muscle cells induced by insulin via down-regulation of insulin receptor expression","volume":"13","author":"Yu","year":"2014","journal-title":"Cardiovascular Diabetology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0760","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0006-2952(99)00010-6","article-title":"Inhibition of human pancreatic islet insulin release by receptor-selective somatostatin analogs directed to somatostatin receptor subtype 5","volume":"57","author":"Zambre","year":"1999","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0765","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/j.1538-7836.2006.01998.x","article-title":"Dopamine modulates von Willebrand factor secretion in endothelial cells via D2-D4 receptors","volume":"4","author":"Zarei","year":"2006","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0770","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/01.HYP.0000114601.30306.bf","article-title":"Aberrant D1 and D3 dopamine receptor transregulation in hypertension","volume":"43","author":"Zeng","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0775","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1161\/01.HYP.0000118958.27649.6f","article-title":"Dopamine D1 receptor augmentation of D3 receptor action in rat aortic or mesenteric vascular smooth muscles","volume":"43","author":"Zeng","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0780","first-page":"183","article-title":"Transcription of dopamine D1A receptor mRNAs in rat heart","volume":"18","author":"Zhang","year":"1996","journal-title":"Methods and Findings in Experimental and Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0785","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1172\/JCI57324","article-title":"Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice","volume":"121","author":"Zhang","year":"2011","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0790","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ncb1563","article-title":"R-type Ca(2+)-channel-evoked CICR regulates glucose-induced somatostatin secretion","volume":"9","author":"Zhang","year":"2007","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0795","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/sj.bjp.0701250","article-title":"Effects of dopamine on L-type Ca2+ current in single atrial and ventricular myocytes of the rat","volume":"121","author":"Zhao","year":"1997","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.07.003_bb0800","first-page":"247","article-title":"Effects of dopamine receptor agonists on the cAMP content in arteries of the rabbit","volume":"52","author":"Zhu","year":"2000","journal-title":"Sheng Li Xue Bao"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725819301299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725819301299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:59:14Z","timestamp":1759010354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725819301299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":160,"alternative-id":["S0163725819301299"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2019.07.003","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopamine outside the brain: The eye, cardiovascular system and endocrine pancreas","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2019.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107392"}}